Fundraising Fox

Afynia

3 known investors

Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.

BiotechDigital HealthFemTechMedical Devices

Founders & leadership

DLDr. Lauren Foster
Dr. Lauren FosterCo-Founder & Chief Executive Officer
DJDr. Jocelyn Wessels
Dr. Jocelyn WesselsCo-Founder & Chief Scientific Officer
DJDr. Jake Prigoff
Dr. Jake PrigoffChief Medical Officer
DFDarren Farry
Darren FarryChief Financial Officer

Investors Β· 3

SOSVβœ“ verifiedNew York Β· $30K – $550K
GaingelsreportedNew York Β· $200K – $500K
Impact America FundreportedIrvine Β· $250K – $3M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports β€” follow each round's link for the claim.

Competitors Β· 2

by search overlap
Affinia Therapeutics4 shared keywordsAffinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions. The company uses AI and structural modeling to redesign viral delivery vectors for one-time-dose genetic medicines across rare and prevalent diseases.
Antheia, Inc.3 shared keywordsAntheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing. The company targets pharmaceutical supply chains, aiming to reduce drug shortages and improve reliability for medicines traditionally derived from plants.

Companies competing with Afynia for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Canadian Biotech Afynia Raises $5M to Commercialize Blood Test for Endometriosis - Femtech Canadafemtech.ca Β· Mar 2025University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis - Innovation Factoryinnovationfactory.ca Β· Mar 2025πŸ’Έ Afynia Laboratories Raises $5M for its Blood Test for Endometriosisfemwealth.substack.com Β· Mar 2025University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis | TechCrunchtechcrunch.com Β· Feb 2025Afynia raises $2 million CAD to bring endometriosis test to market - SOSVindiebio.co Β· Jul 2024Afynia Labs Raises $2M to Improve Healthcare for Women in Canada - Decoder.cadecoder.ca Β· Jul 2024

Frequently asked questions

What does Afynia do?
Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers. The company operates a CLIA laboratory and works on molecular biology testing for reproductive health conditions.
Who founded Afynia?
Afynia was founded by Dr. Lauren Foster, Dr. Jocelyn Wessels.
Who are Afynia's investors?
Afynia's investors include SOSV, Gaingels, Impact America Fund.